Five Prime Therapeutics Inc
CD80 extracellular domain polypeptides and their use in cancer treatment
Last updated:
Abstract:
This application relates to CD80 (B7-1) extracellular domain (ECD) polypeptides and CD80-ECD fusion molecules and their use in treatment of cancer, both alone and in combination with other therapeutic agents, such as immune stimulating agents such as PD-1/PD-L1 inhibitors.
Status:
Grant
Type:
Utility
Filling date:
15 Mar 2019
Issue date:
24 Aug 2021